Pfizer drug hits goals of colorectal cancer study

The latest stories trending on MedCity News.

Editor's Pick

Top Story Pfizer Drug Hits Goals of Colorectal Cancer Study, Clearing Way to Seek Full FDA Approval Pfizer's Braftovi received accelerated FDA approval in December as a first-line treatment for metastatic colorectal cancer with a particular genetic mutation. The pharma giant now says the drug has hit primary and secondary goals of its Phase 3 clinical trial. Sponsored Discover How Mayo Clinic Platform_Solutions Studio Can Accelerate the Commercialization of Your Digital Health Solution. Presented by Mayo Clinic Platform Whether you're ready to build, validate, or deploy your AI solution into clinical workflows, Solutions Studio offers comprehensive technical and business support tailored to your needs.  Learn more.  INVEST 2025 Chicago - Pitch Perfect Application Deadline has been Extended! Each Pitch Track winner will receive a $20,000 advertising credit to be used on MedCityNews.com. The tracks are as follows:  Biopharma (Infectious Diseases) Devices & Diagnostics (Chronic Diseases and Their Management) Healthtech: Consumer/Employer (Care Navigation and Coordination) Healthtech: Payer/Provider (Artificial Intelligence) Apply Now!

Featured News

Tips for Greater Healthcare Practice Success in 2025 [Sponsored] Hidden costs can undermine your healthcare practice. A webinar sponsored by Elation Health will offer insights on how to address them. PBGH Calls on New Congress and Administration to Improve Employee Healthcare in 2 Key Areas In a new brief, the Purchaser Business Group on Health called for policy changes that address healthcare costs and improve access to high-quality care. Unlocking Success in Value-Based Care: Why Focusing on Specialized Populations is Key The shift to a VBC model represents more than an evolution in healthcare delivery – it demands a fundamental redesign of our healthcare system and the economic models to support it.

Resources

MedCity FemFwd: Comparing Maternal Health in Employer-Sponsored Populations vs. Medicaid Presented by MedCity News In this episode, we're joined by Emily Lindemer, an executive director at Morgan Health. Lindemer discusses a recent report she co-authored, which focuses on maternal health opportunities in employer-sponsored insurance. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe